HER2-Mediated Anticancer Drug Delivery: Strategies to Prepare Targeting Ligands Highly Specific for the Receptor

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|21|2525-2538

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.21, 2015-01, pp. : 2525-2538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancing the Site-Specific Targeting of Macromolecular Anticancer Drug Delivery Systems

By  

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 229-235

Bentham Science Publishers

Access to resources Recommend Favorite

Active Targeting Strategies for Anticancer Drug Nanocarriers

By  

Current Drug Delivery, Vol. 9, Iss. 3, 2012-05 ,pp. : 255-268

Bentham Science Publishers

Access to resources Recommend Favorite

Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

By Wartlick Heidrun   Michaelis Kerstin   Balthasar Sabine   Strebhardt Klaus   Kreuter Jörg   Langer Klaus  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 461-471

Informa Healthcare

Access to resources Recommend Favorite

A two-component drug delivery system using Her-2-targeting thermosensitive liposomes

By Kullberg Max   Mann Kristine   Owens Jesse Lee  

Journal of Drug Targeting, Vol. 17, Iss. 2, 2009-02 ,pp. : 98-107

Informa Healthcare

Access to resources Recommend Favorite

Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment

By  

Current Drug Delivery, Vol. 12, Iss. 2, 2015-04 ,pp. : 177-191

Bentham Science Publishers

Access to resources Recommend Favorite